Skip to main content

BSX

Stock

BSX

Stock
Health Care
Medical Devices

Performance overview

BSX Price
Price Chart

Forward-looking statistics

Beta
0.41
Risk
18.67%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

Company info

SectorHealth Care
IndustryMedical Devices
Employees47K
Market cap$113.4B

Fundamentals

Enterprise value$170.1B
Revenue$17.6B
Revenue per employee—
Profit margin11.58%
Debt to equity52.16

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$1.37
Dividend per share—
Revenue per share$11.91
Avg trading volume (30 day)$795M
Avg trading volume (10 day)$785M
Put-call ratio—

Macro factor sensitivity

Growth+1.1
Credit+1.6
Liquidity+0.1
Inflation-1.5
Commodities+0.1
Interest Rates-1.3

Valuation

Dividend yield0.00%
PEG Ratio37.39
Price to sales8.79
P/E Ratio37.39
Enterprise Value to Revenue9.69
Price to book6.95

Upcoming events

Next earnings dayApril 23, 2025
Next dividend day—
Ex. dividend day—

News

Boston Scientific (BSX) Crossed Above the 20-Day Moving Average: What That Means for Investors

Boston Scientific (BSX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, BSX crossed above the 20-day moving average, suggesting a short-term bullish trend.

Zacks Investment Research (July 11, 2025)
3 AI-Driven Medical Device Stocks to Watch in 2025

BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.

Zacks Investment Research (July 11, 2025)
What's Happening With Boston Scientific Stock?

Boston Scientific (NYSE:BSX) has experienced a stock price increase of over 30% in the last twelve months, greatly exceeding the S&P 500's gain of 9%. This remarkable performance can be credited to the launch of new products, which have enhanced sales growth and widened profit margins.

Forbes (June 16, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free